Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1365-2133.1998.02389.x | DOI Listing |
J Cutan Pathol
January 2025
Division of Dermatology, The University of Texas at Austin, Dell Medical School, Austin, Texas, USA.
Pemetrexed is a chemotherapeutic, antimetabolite agent that has been used in oncology to treat diseases such as metastatic non-small cell lung cancer and unresectable malignant pleural mesothelioma. Pemetrexed use may result in pseudocellulitis, which presents as poorly demarcated patches or plaques with erythema, edema, warmth, and tenderness. These lesions can present unilaterally or bilaterally on the lower extremities.
View Article and Find Full Text PDFInt J Dermatol
August 2024
Department of Dermatology, Hospital Universitario Ramon y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain.
Neutrophilic eccrine hidradenitis (NEH) is one of the cutaneous manifestations of chemotherapy side effects. However, it can arise from other non-chemotherapy medications. The granulocyte-colony-stimulating factor is a medication reported to trigger NEH.
View Article and Find Full Text PDFDermatol Clin
April 2024
Department of Dermatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
Front Med (Lausanne)
January 2024
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!